Sleep and Pain in Pediatric Illness: A Conceptual Review

Jennifer M Allen1, Danielle M Graef1, Jennifer H Ehrentraut1

  • 1Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Insights

Pediatric pain often disrupts sleep, impacting children with chronic conditions. Addressing both pain and sleep is crucial for improving their overall health and function.

Area of Science:

  • Pediatric Health
  • Sleep Medicine
  • Pain Management

Background:

  • Sleep disruption is a frequent issue alongside pediatric pain.
  • Pain and sleep problems can be worsened by illness, treatment, and medications.

Purpose of the Study:

  • To review the connection between pain and sleep in children with chronic medical or developmental conditions.
  • To identify common sleep disturbance themes across various pediatric illnesses.
  • To cover conditions including intellectual and developmental disabilities (IDD), migraines, cystic fibrosis (CF), sickle cell disease (SCD), cancer, juvenile idiopathic arthritis (JIA), juvenile fibromyalgia (JFM), and functional gastrointestinal disorders (FGIDs).

Main Methods:

  • This study is a conceptual review of existing literature.
  • It synthesizes information on the pain-sleep relationship in pediatric populations.

Main Results:

  • Children with chronic conditions experience more pain and sleep issues than healthy peers.
  • While subjective sleep complaints are common, objective sleep problems are under-researched.
  • The pain-sleep link is evident in pediatric sickle cell disease, IDD, and JIA, but less studied in other conditions like cancer and JFM.

Conclusions:

  • Assessing and treating both pain and sleep is vital for functional outcomes in children.
  • Future research should focus on objective sleep measures and the mechanisms underlying the pain-sleep relationship.
  • Investigating nonpharmacological interventions for pain and sleep is recommended for vulnerable pediatric groups.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
722
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.7K
Primary Motives: Sleep, Sex, and Pain Avoidance01:24

Primary Motives: Sleep, Sex, and Pain Avoidance

Primary motives such as sleep, sex, and pain avoidance are crucial drivers of behavior in humans and animals. These motives ensure survival, reproductive success, and overall well-being by prompting actions that meet essential bodily needs.
Sleep is a fundamental physiological drive that fosters a state of restfulness crucial for several bodily functions. It facilitates body restoration, the process by which the body repairs, rejuvenates, and maintains itself during sleep, including memory...
6.8K